| __timestamp | Blueprint Medicines Corporation | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 31354781 |
| Thursday, January 1, 2015 | 48588000 | 43445817 |
| Friday, January 1, 2016 | 81131000 | 66489820 |
| Sunday, January 1, 2017 | 144687000 | 96886134 |
| Monday, January 1, 2018 | 243621000 | 153793000 |
| Tuesday, January 1, 2019 | 331450000 | 148369000 |
| Wednesday, January 1, 2020 | 326860000 | 151934000 |
| Friday, January 1, 2021 | 601033000 | 198532000 |
| Saturday, January 1, 2022 | 477419000 | 112128000 |
| Sunday, January 1, 2023 | 427720000 | 76192000 |
| Monday, January 1, 2024 | 341433000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Blueprint Medicines Corporation and TG Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D expenditures.
Since 2014, Blueprint Medicines has consistently increased its R&D spending, peaking in 2021 with a remarkable 1,790% increase from its 2014 levels. This surge underscores the company's commitment to pioneering new therapies and expanding its pipeline.
Conversely, TG Therapeutics has adopted a more conservative strategy, with R&D expenses growing by approximately 150% over the same period. Despite this, the company has made significant strides in its niche, focusing on targeted therapies.
As these two biotech giants continue to innovate, their R&D investments will undoubtedly shape the future of healthcare.
R&D Insights: How Pfizer Inc. and TG Therapeutics, Inc. Allocate Funds
R&D Insights: How Bristol-Myers Squibb Company and TG Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
Comparing Innovation Spending: TG Therapeutics, Inc. and Novavax, Inc.